ANDA 78391, held by Jubilant Cadista. Hydrochlorothiazide.
As of Nov 16, 2026, ANDA 78391 (Hydrochlorothiazide), held by Jubilant Cadista, was first approved by FDA on Feb 11, 2008, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 11, 2008 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydrochlorothiazide12.5MG · capsule;oral | Hydrochlorothiazide | Rx |
| Aug 22, 2024 | Supplement 14Labeling · Standard review | Approved | None posted |
| Feb 11, 2008 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters